News >

Deletion 20q in CLL May Represent Disease Progression

Laura Panjwani
Published: Thursday, May 28, 2015

Lynne V. Abruzzo, MD, PhD

Lynne V. Abruzzo, MD, PhD

The identification of a deletion 20q (del[20q]) in a patient with chronic lymphocytic leukemia (CLL) may not indicate they have developed a myelodysplastic syndrome (MDS) as was previously assumed, according to new research published in Modern Pathology.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Medical Crossfire®: Personalizing Care for Multiple Myeloma Patients: Current and Future Sequencing StrategiesMay 31, 20191.5
Publication Bottom Border
Border Publication
x